P53 Mutation
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer (NCT04159155) | University Health Network, Toronto | 2020-11-17 |
| Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations (NCT04906031) | First Affiliated Hospital of Jinan University | 2020-06-01 |
| A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors (NCT03611868) | Ascentage Pharma Group Inc. | 2018-08-29 |
| Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS) (NCT03377725) | Li Junmin | 2018-03-20 |
| Decitabine,Cytarabine and Arsenic Trioxide for Acute Myeloid Leukemia With p53 Mutations (NCT03381781) | Li Junmin | 2018-03-01 |
| Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS (NCT03855371) | Ruijin Hospital | 2018-01-10 |
Track P53 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.